Atlas Trials

Tailoring of Vaccine-Focused Messages: Disease Salience

Clinical trial NCT03002324 · COMPLETED

Trial details

NCT number
NCT03002324
Sponsor
Emory University
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Human Papillomavirus
Start date
2017-01-01
Primary completion
2017-05-01
Enrollment
1320

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.